相关实验视频
Updated: May 5, 2026

Murine Colitis Modeling using Dextran Sulfate Sodium DSS
Published on: January 19, 2010
在实验性性结肠炎模型小鼠中,Artesunate通过促进HMGCS2-依赖的生成来促进肠上皮屏障的修复
Guan Wang1, Lizhuang Han2, Haimei Sun3
1Department of Histology and Embryology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China; School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou 325000, China.
在性结肠炎 (UC) 小鼠中,阿特苏纳酸治疗通过增强生成和改善肠道屏障完整性,恢复了肠道屏障功能. 这种治疗效果与AMPK/mTOR途径有关.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,肠道上皮屏障受损.
- 失调的生成是UC病变的潜在因素,但机制尚不清楚.
研究的目的:
- 调查生成在UC中的作用和阿尔特苏纳酸 (ART) 的治疗潜力.
- 阐明涉及ART对肠道屏障影响的信号通路.
主要方法:
- 德克斯硫酸盐 (DSS) 在小鼠中诱导UC.
- 评估了肠上皮质屏障功能,Th17/Treg比率和HMGCS2表达.
- 在体内和体外研究了ART,AMPK抑制剂和mTOR激活剂的影响.
主要成果:
- UC小鼠显示屏障功能障碍,降低HMGCS2,并减少了生成.
- 治疗ART增加了HMGCS2和生成,恢复了屏障功能和Th17/Treg平衡.
- 抑制AMPK或激活mTOR可以逆转ART的有益作用.
结论:
- 通过AMPK/mTOR通路刺激HMGCS2依赖的生成,ART促进UC中的肠上皮屏障修复.
- 向生成代表了性结肠炎的潜在治疗策略.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease II: Ulcerative Colitis